120 related articles for article (PubMed ID: 4089529)
1. Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients.
Garewal HS; Durie BG
Scand J Haematol; 1985 Nov; 35(5):497-500. PubMed ID: 4089529
[TBL] [Abstract][Full Text] [Related]
2. Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.
Antun AG; Gleason S; Arellano M; Langston AA; McLemore ML; Gaddh M; el Rassi F; Bernal-Mizrachi L; Galipeau J; Heffner LT; Winton EF; Khoury HJ
Cancer; 2013 Nov; 119(21):3784-7. PubMed ID: 23921838
[TBL] [Abstract][Full Text] [Related]
3. Aminocaproic acid. Use in control of hemorrhage in patients with amegakaryocytic thrombocytopenia.
Gardner FH; Helmer RE
JAMA; 1980 Jan; 243(1):35-7. PubMed ID: 6965311
[TBL] [Abstract][Full Text] [Related]
4. Epsilon-aminocaproic acid (EACA).
Griffin JD; Ellman L
Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
[TBL] [Abstract][Full Text] [Related]
5. Control of bleeding after renal biopsy with epsilon-amino-caproic acid.
Savdie E; Mahony JF; Storey BG
Br J Urol; 1978 Feb; 50(1):8-11. PubMed ID: 630206
[TBL] [Abstract][Full Text] [Related]
6. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
Burchiel KJ; Hoffman JM; Bakay RA
Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
Fish SS; Pancorbo S; Berkseth R
J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
[TBL] [Abstract][Full Text] [Related]
10. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
[TBL] [Abstract][Full Text] [Related]
12. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
[TBL] [Abstract][Full Text] [Related]
13. Epsilon-aminocaproic acid in the reversal of consumptive coagulopathy with platelet sequestration in a vascular malformation of Klippel-Trenaunay syndrome.
Poon MC; Kloiber R; Birdsell DC
Am J Med; 1989 Aug; 87(2):211-3. PubMed ID: 2547315
[No Abstract] [Full Text] [Related]
14. Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.
Wassenaar T; Black J; Kahl B; Schwartz B; Longo W; Mosher D; Williams E
Hematol Oncol; 2008 Dec; 26(4):241-6. PubMed ID: 18613223
[TBL] [Abstract][Full Text] [Related]
15. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
[TBL] [Abstract][Full Text] [Related]
16. Epsilon aminocaproic acid in hemophiliacs undergoing dental extractions: a concise review.
Lucas ON; Albert TW
Oral Surg Oral Med Oral Pathol; 1981 Feb; 51(2):115-20. PubMed ID: 6782532
[TBL] [Abstract][Full Text] [Related]
17. The treatment of postperfusion bleeding using epsilon-aminocaproic acid, cryoprecipitate, fresh-frozen plasma, and protamine sulfate.
Lambert CJ; Marengo-Rowe AJ; Leveson JE; Green RH; Thiele JP; Geisler GF; Adam M; Mitchel BF
Ann Thorac Surg; 1979 Nov; 28(5):440-4. PubMed ID: 496496
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic treatment of postperfusion bleeding using EACA.
DelRossi AJ; Cernaianu AC; Botros S; Lemole GM; Moore R
Chest; 1989 Jul; 96(1):27-30. PubMed ID: 2736988
[TBL] [Abstract][Full Text] [Related]
19. epsilon-Amino-caproic acid in the management of acute promyelocytic leukaemia.
Keane TJ; Gorman AM; O'Connell LG; Fennelly JJ
Acta Haematol; 1976; 56(4):202-4. PubMed ID: 826076
[TBL] [Abstract][Full Text] [Related]
20. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
Schwartz BS; Williams EC; Conlan MG; Mosher DF
Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
